Get started
Author

Estela Kiouri

Observed names: E Kiouri, E. KiourI, E. Kiouri
ORCID: 0000-0002-9120-7511
Observed ORCID: 0000-0002-9120-7511
OpenAlex ID: A5085745655
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
2021 · Antonio J. Vallejo-Vaz, Christophe A.T. Stevens, et al. · The Lancet · 339
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study
2023 · Kanika Inamdar Dharmayat, Antonio J. Vallejo-Vaz, et al. · The Lancet · 92
PDF
PCSK9 inhibitors in clinical practice: Novel directions and new experiences
2019 · Loukianos S. Rallidis, Ioannis Skoumas, et al. · Hellenic Journal of Cardiology · 32
PDF
LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments
2021 · Christos V. Rizos, Ioannis Skoumas, et al. · International Journal of Cardiology · 29
Prevalence of heterozygous familial hypercholesterolemia and combined hyperlipidemia phenotype in very young survivors of myocardial infarction and their association with the severity of atheromatous burden
2019 · Loukianos S. Rallidis, Nikolaos Kosmas, et al. · Journal of clinical lipidology · 19
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
2024 · Amany Elshorbagy, Alexander R.M. Lyons, et al. · The Lancet Diabetes & Endocrinology · 17
Homocysteine is an independent predictor of long-term cardiac mortality in patients with stable coronary artery disease in the era of statins
2019 · Loukianos S. Rallidis, Nikolaos Kosmas, et al. · Coronary Artery Disease · 15
Extreme-risk category: High prevalence among stable coronary patients and an emerging widening treatment gap in achieving LDL-cholesterol less than 55 mg/dL
2018 · Loukianos S. Rallidis, Estela Kiouri, et al. · Atherosclerosis · 13
Achieving low-density lipoprotein cholesterol targets as assessed by different methods in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH registry
2020 · Christos V. Rizos, Matilda Florentin, et al. · Lipids in Health and Disease · 12
PDF
Familial Hypercholesterolemia in the Elderly: An Analysis of Clinical Profile and Atherosclerotic Cardiovascular Disease Burden from the Hellas-FH Registry
2024 · Christina Antza, Christos V. Rizos, et al. · Biomedicines · 10
PDF
Obesity and atherosclerotic cardiovascular disease in adults with heterozygous familial hypercholesterolemia: An analysis from HELLAS-FH registry
2024 · Fotios Barkas, Christos V. Rizos, et al. · Journal of clinical lipidology · 8
Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH
2022 · Panagiotis Anagnostis, Christos V. Rizos, et al. · Endocrine · 8
Prevalence of Diabetes and Its Association with Atherosclerotic Cardiovascular Disease Risk in Patients with Familial Hypercholesterolemia: An Analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)
2022 · Chrysoula Boutari, Christos V. Rizos, et al. · Pharmaceuticals · 7
PDF
Physical signs and atherosclerotic cardiovascular disease in familial hypercholesterolemia: the HELLAS-FH Registry
2024 · Loukianos S. Rallidis, Christos V. Rizos, et al. · Journal of Cardiovascular Medicine · 6
Hyperhomocysteinemia as the only risk factor in a young man presenting with ST-elevation myocardial infarction
2020 · Charalampos Varlamos, Christos Pappas, et al. · Journal of Cardiology Cases · 5
PDF
Exploring the correlation between triglyceride levels and atherosclerotic cardiovascular disease prevalence in adults with familial hypercholesterolemia: Insights from a cross-sectional analysis in the HELLAS-FH registry
2025 · Panagiotis Anagnostis, Christos V. Rizos, et al. · Journal of clinical lipidology · 2
Gradually increased stress levels in the days leading to an acute myocardial infarction, detected by a new biomarker-based approach
2022 · N Kosmas, D Zapantiotis, et al. · European Heart Journal · 2
Prevalence of non-coronary heart disease in patients with familial hypercholesterolemia: An analysis from the HELLAS-FH
2021 · P. Anagnostis, C. Rizos, et al. · Atherosclerosis · 2
Cholesterol levels of high-density lipoprotein (HDL-C), APOB/APOA1 ratio and cardiovascular risk in patients with familial hypercholesterolemia (FH): Data from the HELLAS-FH registry
2020 · C. Rizos, G. Liamis, et al. · Atherosclerosis · 1
Identification and characterization of a rare variant in apolipoprotein A-IV, p.(V336M), and evaluation of HDL functionality in a Greek cohort with extreme HDL cholesterol levels
2020 · Angeliki Chroni, Loukianos Rallidis, et al. · Archives of Biochemistry and Biophysics · 1
The incremental value of copeptin with high-sensitivity troponin t for the early rule-out of acute myocardial infraction in the emergency department
2026 · S Bezati, C Verras, et al. · European Journal of Heart Failure
Can FoCUS Speed Up the Management of Acute Coronary Syndrome in the Emergency Department?
2026 · Melina Karaolia, Sofia Bezati, et al. · Medicina
The Incremental Value of Copeptin for the Early Rule-Out of Non-ST Elevation Myocardial Infarction in the Emergency Department
2026 · Sofia Bezati, Christos Verras, et al. · Journal of Clinical Medicine
PDF
Cardiovascular events in hospitalized patients with COVID-19: incidence, in-hospital mortality, and fatality rates. Results from the HERICCO study by the Working Group of Echocardiology of the Hellenic Cardiology Society
2025 · Ilias Karabinos, Ilias Gkartzonikas, et al. · Hellenic Journal of Cardiology
Cardiometabolic profile of children with heterozygous familial hypercholesterolemia: Updated data from the HELLAS-FH registry
2024 · Christos Rizos, Haralampos Milionis, et al. · Atherosclerosis
PDF
Works count: 52
Citation count: 620
H-index: 10
I10-index: 10
Year
Topic
Type